Lessons learned in managing risk : Tools and strategies for confident operations from the CLEAN 2020 Summit
Risk mitigation of COVID-19 in the indoor environment requires an articulated strategy for creating a bridge between science and the business community that focuses on knitting together four core capabilities-environmental microbiology, transmission science, building science, and social science-advancing scientific knowledge. The purpose of this article is to share insights from the CLEAN 2020 Summit, which assembled leaders from business, policy, standards development, science, and engineering working to mitigate risk of transmission in the built environment. The Summit worked to assess current challenges and pain points felt by industries from around the globe as well as innovative solutions applied to meet these challenges. Although SARS-CoV-2 and the COVID-19 diseases are unique, the foundation of knowledge to assess and mitigate the risk of viral transmission in the built environment is robust. There are opportunities to improve science and engineering technology solutions, processes, and procedures to better meet the dynamic needs of the evolving pandemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Toxicology and industrial health - 36(2020), 9 vom: 17. Sept., Seite 736-742 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Martinez, Kenneth F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Built environment |
|---|
| Anmerkungen: |
Date Completed 10.12.2020 Date Revised 14.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1177/0748233720971381 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318083353 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318083353 | ||
| 003 | DE-627 | ||
| 005 | 20231225164620.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/0748233720971381 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318083353 | ||
| 035 | |a (NLM)33241768 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martinez, Kenneth F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lessons learned in managing risk |b Tools and strategies for confident operations from the CLEAN 2020 Summit |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.12.2020 | ||
| 500 | |a Date Revised 14.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Risk mitigation of COVID-19 in the indoor environment requires an articulated strategy for creating a bridge between science and the business community that focuses on knitting together four core capabilities-environmental microbiology, transmission science, building science, and social science-advancing scientific knowledge. The purpose of this article is to share insights from the CLEAN 2020 Summit, which assembled leaders from business, policy, standards development, science, and engineering working to mitigate risk of transmission in the built environment. The Summit worked to assess current challenges and pain points felt by industries from around the globe as well as innovative solutions applied to meet these challenges. Although SARS-CoV-2 and the COVID-19 diseases are unique, the foundation of knowledge to assess and mitigate the risk of viral transmission in the built environment is robust. There are opportunities to improve science and engineering technology solutions, processes, and procedures to better meet the dynamic needs of the evolving pandemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Risk assessment | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a built environment | |
| 650 | 4 | |a summit | |
| 700 | 1 | |a Morrow, Jayne B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Toxicology and industrial health |d 1993 |g 36(2020), 9 vom: 17. Sept., Seite 736-742 |w (DE-627)NLM013050850 |x 1477-0393 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2020 |g number:9 |g day:17 |g month:09 |g pages:736-742 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/0748233720971381 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2020 |e 9 |b 17 |c 09 |h 736-742 | ||